Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
Clinical trial NCT04817254 · COMPLETED
Trial details
- NCT number
- NCT04817254
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-08
- Primary completion
- 2026-03-20
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.